These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6210171)

  • 61. [The carcinoid syndrome and serotonin].
    HEDINGER C
    Helv Med Acta; 1958 Oct; 25(4):351-81. PubMed ID: 13610213
    [No Abstract]   [Full Text] [Related]  

  • 62. [The carcinoid syndrome].
    Laplante L; Archambault A; Thibert F
    Union Med Can; 1971 Oct; 100(10):1970-84. PubMed ID: 5316830
    [No Abstract]   [Full Text] [Related]  

  • 63. [Carcinoid syndrome (apropos of 1 case). II. Biologic study and therapeutic note].
    Dreux C; Ingrand J
    Bull Mem Soc Med Hop Paris; 1967 Feb; 119(4):403-12. PubMed ID: 5596409
    [No Abstract]   [Full Text] [Related]  

  • 64. [Enterochromaffin cells and carcinoid syndrome].
    Tobe T
    Nihon Rinsho; 1974 Apr; 32(4):745-50. PubMed ID: 4858960
    [No Abstract]   [Full Text] [Related]  

  • 65. [Serotonin and carcinoid syndrome].
    MEEROFF M; MARCOS P; SKLIAR ZB
    Prensa Med Argent; 1958 Nov; 45(47):3687-93. PubMed ID: 13667809
    [No Abstract]   [Full Text] [Related]  

  • 66. [Malignant carcinoid syndrome].
    Escartín Marín P; Chantar Barrios C; Anaya Munne A; Segovia de Arana JM
    Rev Clin Esp; 1968 Oct; 111(1):27-36. PubMed ID: 5742414
    [No Abstract]   [Full Text] [Related]  

  • 67. [The problem of metabolic processes in the yellow cell organ and carcinoid of the gastrointestinal tract].
    FEYRTER F
    Wien Klin Wochenschr; 1959 Sep; 71():727-31. PubMed ID: 13822592
    [No Abstract]   [Full Text] [Related]  

  • 68. Neuropharmacological therapy of carcinoid syndrome.
    Lechin F; van der Dijs B
    Neuroendocrinology; 2005; 81(3):137-8. PubMed ID: 15976511
    [No Abstract]   [Full Text] [Related]  

  • 69. Serotonin storage in the carcinoid syndrome.
    May B; Bak IJ; Böhle E; Hassler R
    Ger Med Mon; 1969 Aug; 14(8):408-9. PubMed ID: 5349670
    [No Abstract]   [Full Text] [Related]  

  • 70. Dopamine and basal ganglia disorders.
    O'Reilly S; Loncin M; Cooksey B
    Neurology; 1965 Nov; 15(11):980-4. PubMed ID: 5892413
    [No Abstract]   [Full Text] [Related]  

  • 71. [The metabolism of serotonin and the carcinoid syndrome].
    GRAY SJ
    Rev Med Chil; 1961 Nov; 89():956-9. PubMed ID: 13901325
    [No Abstract]   [Full Text] [Related]  

  • 72. MALABSORPTION IN MALIGNANT CARCINOID WITH NORMAL 5 HIAA.
    NASH DT; BRIN M
    N Y State J Med; 1964 May; 64():1128-31. PubMed ID: 14147170
    [No Abstract]   [Full Text] [Related]  

  • 73. Neuroendocrine neoplasms and their cells of origin.
    Tischler AS; Dichter MA; Biales B; Greene LA
    N Engl J Med; 1977 Apr; 296(16):919-25. PubMed ID: 846514
    [No Abstract]   [Full Text] [Related]  

  • 74. [Carcinoid syndrome and anesthesiology. Review and personal contribution].
    Horno González R; Gómez-Arnau J; Gilsanz Rodríguez F; Avello García F
    Rev Esp Anestesiol Reanim; 1982 Nov; 29(6):348-52. PubMed ID: 7170373
    [No Abstract]   [Full Text] [Related]  

  • 75. Carcinoid syndrome with unknown primary: a case report.
    Mahmood T; Mudad R
    Am J Clin Oncol; 1999 Aug; 22(4):384-6. PubMed ID: 10440195
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Carcinoid syndrome].
    Miszputen SJ
    Arq Gastroenterol; 1993; 30(1):1-3. PubMed ID: 8240059
    [No Abstract]   [Full Text] [Related]  

  • 77. [Hydroxytryptamine and hydroxyindolacetic acid determination in a case of carcinoid syndrome, with a study on hydroxytryptamine].
    LANGEMANN H; KAGI J
    Klin Wochenschr; 1956 Mar; 34(9-10):237-41. PubMed ID: 13333003
    [No Abstract]   [Full Text] [Related]  

  • 78. The rapid degradation of 5-hydroxytryptamine (serotonin): significance in the carcinoid syndrome.
    JOHNSON LL; PESKIN GW; SENESKY DJ
    Surg Forum; 1961; 12():332-3. PubMed ID: 14452068
    [No Abstract]   [Full Text] [Related]  

  • 79. [Serotonin increase in blood without increased 5-hydroxyindoleacetic acid excretion].
    Eysell K; Venrath H; Franzen F
    Med Welt; 1965 Jul; 28():1594-8. PubMed ID: 5838806
    [No Abstract]   [Full Text] [Related]  

  • 80. [Symptoms & diagnosis of malignant argentaffinoma (carcinoidosis)].
    WALDENSTROM J
    Brux Med; 1957 Aug; 37(32):1183-8. PubMed ID: 13460397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.